Atlas Trials

ENCOrafenib With Binimetinib in bRAF NSCLC

Clinical trial NCT04526782 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04526782
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung CancerBRAF V600E
Start date
2021-01-19
Primary completion
2025-07-16
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.